Background: Analyses of predictive factors for local recurrences are important, as an increasing number of patients with early breast cancer opt for a breast-conserving procedure. This study investigates whether factors predictive of local recurrence differ between patients treated with conservative or radical surgery.
Introduction
Several publications have analyzed prognostic factors potentially related to the risk of local recurrence (LR) in early breast cancer [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . By restricting their analysis to breastconserving surgery (BCS) series, some authors recently reported that the main factors significantly related to the risk of LR were young age [2, 6, [18] [19] , a high histological grade [11, 15, 18, 20] and an extensive intraductal component [7, [21] [22] ; and surgical margins [8, 11, [23] [24] [25] [26] [27] [28] and local radiotherapy were treatment factors [29] [30] [31] [32] [33] [34] [35] [36] . However, it is not clear whether prognostic factors for LR are similar for patients treated with BCS and those treated with total mastectomy. For instance, axillary lymph node involvement, which is a powerful prognostic factor in non-irradiated mastectomy series [37] [38] [39] [40] [41] , does not appear to have a significant local impact in BCS series [15] [16] . A recent study on substantial randomized data concluded that age is a prognostic factor for LR in patients treated with BCS and that vascular invasion is prognostic for both BCS and mastectomy [17] .
To search for additional information on this subject, we compared the factors related to the risk of LR in patients treated with a different surgical approach, in a series of operable breast cancer that originated from the Institut GustaveRoussy (IGR) database. To avoid biases related to tumor size, we limited the analysis to patients whose tumor was ≤25 mm.
Patients and methods

Patients
From a cohort of 7711 patients with invasive breast carcinoma treated at the IGR between 1954 and 1983, we abstracted 2006 patients with the following characteristics: (i) age <75 years; (ii) unilateral infiltrating carcinoma, clinically classified as T0-T2, N0-N1, M0 according to the International Union Against Cancer (UICC) system; (iii) tumor size ≤25 mm; (iv) no previous biopsy performed outside the IGR; (v) a documented histological grade; (vi) initial surgical treatment that was either BCS or a total mastectomy, including systematic axillary dissection (and dissection of the internal mammary chain in 33% of mastectomy cases); and (vii) radiotherapy after BCS or after mastectomy if patients had positive axillary nodes. The histological grading was according to the modified Scarff-Bloom-Richardson (SBR) classification, as described previously [42] .
Tumor size was determined during the perioperative macroscopic examination of the fresh tumorectomy specimen by direct measure of the greatest tumor diameter. This examination also permitted verification of, for patients to be treated with BCS, the presence of a minimum of 1 cm of macroscopically normal breast tissue surrounding the tumor, or to request, if necessary, an additional surgical excision. For the processing of axillary lymph nodes after tissue fixation, each lymph node identified during dissection was included in entirety in the macroscopic serial slices [43] .
The series included 717 patients treated with BCS [452 with negative axillary nodes (N-) and 265 with positive axillary nodes (N+)] and 1289 treated with total mastectomy (622 N-, 667 N+). The mean duration of follow-up was 20 years (standard deviation 7 years) for survivors.
Treatment
For N-patients, external megavoltage irradiation exclusively encompassed the breast in BCS cases and was omitted in total mastectomy cases regardless of the tumor site. For N+ patients, the irradiation fields encompassed the breast and/or chest wall, and locoregional (axillary, supraclavicular and internal mammary chain) lymph nodes. The radiation dose delivered was 45 Gy in 18 fractions and patients submitted to BCS systematically received a boost dose of 15 Gy in six fractions [44] .
Patients with negative nodes did not receive systemic adjuvant treatment. For N+ patients, ovarian suppression was achieved with radiotherapy in 26% of cases, and chemotherapy or additive hormonal therapy were given in only 3% of patients.
Statistical methods
The main end point was the total local recurrence rate. LR was defined as any recurrence in the breast or chest wall, and the total number of LR was 211. The mean disease-free interval between initial surgery and recurrence was 6.8 years (SD 5.6 years).
We studied the relationship between the risk of LR and six clinical and histological covariates, i.e. age at diagnosis of the primary tumor, macroscopic tumor size, SBR grade, tumor location (inner quadrants compared with other sites), and the number of examined and involved axillary lymph nodes.
The risk of LR was estimated using the Cox proportional hazard model [45] , and analysis began from the date of diagnosis of the primary tumor. Censoring began either on the date of a LR, or the date of the last medical follow-up or death for patients without a LR. Any other events such as metastases or a new primary were not censored.
First, we analyzed negative and positive axillary nodes separately because indications for radiotherapy differed according to the histological status of axillary nodes. Secondly, to determine to what extent the type of surgery or the lymph node status could modify the effect of other factors, or similarly to what extent the latter factors could modify the effect of the former factors, we used interaction tests for the total patient population [46] [47] [48] . Interactive effects were assessed by the likelihood ratio tests used to compare the goodness of fit of the models with and without the interaction term [48] . The interaction tests were performed by introducing multiplicative terms for the factors of interest, i.e. lymph node involvement and surgical treatment groups.
Results
Patient characteristics and local recurrence rates
The distribution of patient characteristics according to surgical treatment and the corresponding 10-year local recurrence rates are shown in Table 1 . Patients with histological grade 2 and 3 tumors yielded a similar 10-year local recurrence rate of 10% [95% confidence interval (CI) 7% to 13%] compared with 5% (95% CI 3% to 7%). Grade 2 and 3 tumors were then pooled in the analysis. The only categories with a risk of local recurrence exceeding 20% at 10 years were found in the BCS group among younger patients (110 cases), and those with four to nine positive axillary lymph nodes (only 46 cases).
Negative axillary nodes
There were 1074 N-patients of whom 121 developed a LR: 452 had undergone BCS (67 LR) and 622 a mastectomy (54 LR). All analyzed factors were included in a multivariate Cox model (Table 2) , first in the BCS group and then in the mastectomy group. In the BCS group, only a young age at diagnosis and inner quadrant tumors were associated with a higher risk of LR. In the mastectomy group, only a high histological grade significantly increased the risk of LR.
Positive axillary nodes
Among 932 N+ patients, 90 developed a LR: 265 had undergone BCS (44 LR) and 667 a mastectomy (46 LR). Results are shown in Table 3 . As in N-patients, age and the tumor location were predictive factors in patients treated with BCS. The most important predictive factor in patients treated with mastectomy was the number of positive axillary lymph nodes, followed by tumor location.
Total series and interaction tests according to nodal status and type of surgery
The analyses of prognostic factors in subgroups according to the lymph node status and type of surgery are better conducted by applying interaction tests to the subcategories under consideration. We first studied, for each type of surgery, the interaction between the effect of each factor on the risk of LR according to the lymph node status. No specific differences were found for any factor analyzed (except for the number of positive axillary lymph nodes, which obviously could not be tested). This is why we pooled N+ and N-patients, and the first analysis of the total series is shown in Table 4 . When the entire study population (2006 patients) was taken into account, a young age remained a predictive factor for LR in the BCS group. In the total mastectomy group, only the histological grade was significant and the macroscopic tumor size was of borderline significance. When patients with negative axillary nodes were included, the effect of the number of those who were N+ disappeared and it was of borderline significance for patients with 10 or more involved nodes.
In the second analysis, we compared the two surgical approaches separately for each of the three factors for which the interaction tests had a P value ≤0.10 ( Table 5 ). Age at diagnosis was strongly associated with a high risk of LR in patients treated with BCS. The risk of LR was five-fold greater for patients aged ≤40 years compared with patients >61 years of age. However, the risk of LR was not significantly modified by age in patients treated by mastectomy (P = 0.30). The difference between the treatment groups with respect to the effect of young age is clearly shown by the interaction test, which was highly significant (P = 10 -6 ). In addition, the effect of age in the BCS group was analyzed, taking into account seven age categories rather than only four. Results adjusted for all other significant factors are shown in Figure 1 , with observed and theoretical values calculated by the model. There were also small differences for two other factors, macroscopic tumor size (P = 0.06) and histological grade (P = 0.10), but they were of borderline significance as shown in Table 4 . The relationship between the risk of LR and the location of the tumor, or the number of examined or involved lymph nodes was similar for both surgical approaches (P = 0.87, 0.65 and 0.20, respectively), and results shown include both surgical groups. It is, however, noteworthy that patients with extensive lymph node involvement (10 or more nodes) had a greater risk of LR despite postoperative radiotherapy.
Discussion
Studies evaluating factors predictive of cancer recurrence are important as they provide information on how the disease evolves after primary treatment. Such information may modify conventional treatment attitudes and this is why it is (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) critical that potential biases related to this type of analysis are reduced to a minimum [49] [50] [51] [52] [53] [54] . In the present study, designed to identify differences in predictive factors for LR between patients treated with BCS and those treated with total mastectomy, a number of precautions were taken in the planned analyses. These precautions can be divided into those related to patient selection and those related to the analysis itself. Those relating to the former were: (i) the inclusion of patients with tumors of macroscopic size ≤25 mm (this tumor size cutoff was determinant in the decision for BCS or mastectomy at the IGR; BCS was initiated at this center in the early 1970s [11] ); (ii) all patients had systematic axillary dissection; and (iii) all patients with N+ disease received lymph node irradiation. Precautions related to the analysis comprised: (i) defining LR as a total event rate, i.e. no censoring of other tumor events (this definition limits the risk of biases related to competing events [55] [56] [57] [58] [59] ); (ii) systematically using multivariate analyses to identify the independent predictive effect of each factor; and (iii) avoiding false-positive results in subgroup analyses [60] . Interaction tests were applied for two major variables: axillary lymph node involvement and the surgical treatment. When interaction tests were non-significant, pooled analyses were conducted (N-and N+ patients in Tables 4 and  5) , and when they were significant (or of borderline significance), separate analyses were performed (type of surgical treatment according to age and two histological features in Table 5 ). These precautions do not totally eliminate the likelihood that results may be serendipitously misinterpreted, but they were taken to avoid interpreting errors as much as possible. Our findings are summarized and discussed according to each factor analyzed. The cutoff at 40 years, used to define young age, took into account the number of patients available (248 in total, 12% of the total population). The increased risk of LR (P = 0.07) for patients treated with BCS was demonstrated to be of borderline significance according to the trend tests for N- (Table 2) and N+ patients ( Table 3 ). The possible lack of power in the statistical analysis of these subgroup analyses was confirmed by the highly significant trend test (P = 10 -4 ) for the total number of BCS cases (717) as shown in Table 4 . This effect of young age was totally different to that found in patients treated with mastectomy according to the test presented in Table 5 , where both surgical approaches were compared directly (interaction test with a P value of 10 -6 ). The effect of young age on the risk of LR for patients treated with BCS has been recognized in most studies on prognostic factors [2, 6, 15, 18, 19, 61] . The recent study by Voogd et al. [17] , conducted in a randomized population of 1772 patients (879 treated with BCS and 893 with mastectomy), corroborated this fact. Two differences should be pointed out between this analysis and our own. The first is that Voogd et al. used separate tests for each age group whereas we used a trend test for all age groups. This latter analysis allowed us to test the whole series and not make assumptions about an age cutoff value. Indeed, both studies clearly indicate that there is no obvious age cutoff, and that a young age is rather related to a continuous trend towards a higher risk of LR. This is clearly observed in Figure 1 , where there is only a decreased effect of age after 50 years. This change in the trend could be related to the menopausal status. The second difference is that Voogd et al. did not directly compare patients treated with BCS with those treated with mastectomy (despite the fact that data on this specific treatment factor were randomized). In our study, we applied interaction tests to decrease the likelihood of biases related to the comparison of non-randomized data, which obviously attract criticism. The extremely low P value yielded by such a test in our series allows us to predict that similar results would have been obtained with the Danish-EORTC (European Organization for Research and Treatment of Cancer) data.
Few series have taken tumor location into account [5, 62, 63] . We included this factor as it was registered systematically in the IGR database. As shown in Tables 3-4 , inner quadrant tumors were found to exhibit a trend towards a higher risk of LR. There was no difference between the surgical approaches, as shown in Table 5 , using a non-significant interaction test (P = 0.87). Fowble et al. and Lohrisch et al. [62, 63] found no relationship between tumor location and local recurrence in their series. Macroscopic tumor size (pT) was also taken into account. Due to the initial patient selection, variation in tumor sizes was very limited. This factor was not predictive of the risk of LR for lesions measuring up to 25 mm in the BCS group. The effect of larger tumors (16-25 mm) in the mastectomy group was of borderline significance and it should probably be rejected, since the P value of the interaction test was also low (P = 0.06). Furthermore, in larger series of mastectomized patients in the same IGR database, which included all tumor sizes, we found that tumor size had no effect on local recurrence [64] . However, for patients treated with BCS it would be of interest to continue investigations into the potential effect of tumor size. These studies should be conducted in randomized trials evaluating BCS and including patients with a tumor >3 cm [30, 65] . Incidentally, the report by Voogd et al. [17] showed a non-significant trend towards a higher risk of LR for patients with tumors >1 cm in diameter.
As shown in Table 4 , SBR grade was a predictive factor for LR in mastectomized patients, as we and others have reported elsewhere [64, 66] . However, there is no demonstrated difference between BCS and mastectomy groups as shown in Table 5 , where the interaction test was not significant (P = 0.10). In the trials reported by Voogd et al. [17] , histological grade was of borderline significance in the BCS group (P = 0.07) when other factors such as vascular invasion were taken into account. A general effect may exist but very large numbers would be required to attain statistical significance.
The number of axillary lymph nodes examined was not predictive of LR in any of the analyses, and its prognostic value should be rejected in patients with small tumors in whom the risk of having positive axillary nodes was low.
The number of positive axillary nodes was not a predictive factor for LR in the BCS group with N+ patients, but it was a highly significant factor for mastectomized patients (Table 3 ; 
This effect has been reported previously [64] . However, this effect disappeared when N+ patients were pooled with N-patients (Table 4) , and only extensive axillary involvement (10 or more nodes) maintained a prognostic value as seen in Tables 4 and 5 . It is noteworthy that all N+ patients received loco-regional radiotherapy and this treatment could have canceled the prognostic effect of the number of axillary nodes involved. A similar effect was described in the report by Voogd et al. [17] . Other factors such as extensive intraductal carcinoma [7, [21] [22] and surgical margins [8, 11, [23] [24] [25] [26] [27] [28] were not analyzed as they were not systematically coded in the database. However, the treatment policy at the IGR was to perform total mastectomy when the first factor was present and to request adequate surgical margins, i.e. at least 1 cm of macroscopically normal breast tissue surrounding the tumor when BCS was performed.
In summary, between the BCS and the mastectomy groups, the overriding differential effect predicting the risk of LR was young age. Conservatively treated patients aged 40 years or younger had a five-fold greater risk of LR compared with patients older than 60 years of age who had a baseline risk of LR of 6% at 10 years. This effect was not observed among mastectomized patients. Young age has also been described as a significant prognostic factor for overall survival [67] [68] [69] [70] [71] . That local recurrence may have an impact on distant metastasis and overall survival is also becoming widely recognized [35, [37] [38] [39] [40] [72] [73] [74] [75] [76] [77] [78] . However, as systemic treatments also have a positive impact on local control [79, 80] it can be hypothesized that the current indications for these treatments in intermediate-and high-risk patients could lower the effect of age on tumor recurrence, as observed in the present series. It may prove increasingly important to analyze the long-term results (20 years or more) of all randomized trials comparing systemic treatment with no systemic treatment in patients having undergone BCS. At the present time and given the consistency of the results yielded by different studies on prognostic factors, surgeons and oncologists should be aware of the increased risk of local recurrence in younger patients with early breast cancer treated with BCS. In particular, these patients should be followed up on a regular basis for several years so that any sign of local failure can be diagnosed early. 
